PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

The European Medicines Group (EMG) has appointed Sanofi’s Rippon Ubhi as its new chair. Ubhi, who will maintain her position ...

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and ...

New Environmental, Social and Governance (ESG) regulations coming into force across the EU in 2025 stand to shift how ...

The medical communications (med comms) industry is critical in bridging the gap between new medical innovations, healthcare ...

Following the exciting 2022 in-person Communiqué Awards, we are pleased to offer our readers a selection of case studies that ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug has been recommended by the European Medicines Agency’s human medicines ...